Tisdag 29 September | 18:03:55 Europe / Stockholm
Est. tid*
2027-03-09 08:00 Kvartalsrapport 2027-Q2
2026-11-06 N/A X-dag ordinarie utdelning HEALTH 0.00 EUR
2026-11-05 N/A Årsstämma
2026-09-16 - Bokslutskommuniké 2026
2026-03-05 - Kvartalsrapport 2026-Q2
2025-11-07 - X-dag ordinarie utdelning HEALTH 0.00 EUR
2025-11-06 - Årsstämma
2025-09-18 - Bokslutskommuniké 2025
2025-03-06 - Kvartalsrapport 2025-Q2
2024-11-11 - X-dag ordinarie utdelning HEALTH 0.00 EUR
2024-11-08 - Årsstämma
2024-09-20 - Bokslutskommuniké 2024
2024-03-07 - Kvartalsrapport 2024-Q2
2023-11-17 - X-dag ordinarie utdelning HEALTH 0.00 EUR
2023-11-16 - Årsstämma
2023-09-28 - Bokslutskommuniké 2023
2023-04-24 - Extra Bolagsstämma 2023
2023-03-23 - Kvartalsrapport 2023-Q2
2022-11-17 - Årsstämma
2022-10-25 - X-dag ordinarie utdelning HEALTH 0.00 EUR
2022-09-29 - Bokslutskommuniké 2022
2022-06-29 - Extra Bolagsstämma 2022
2022-02-24 - Kvartalsrapport 2022-Q2
2021-10-29 - X-dag ordinarie utdelning HEALTH 0.00 EUR
2021-10-28 - Årsstämma
2021-09-15 - Bokslutskommuniké 2021
LandFinland
ListaSmall Cap Helsinki
SektorHälsovård
IndustriMedicinteknik
Nightingale Health är verksamt inom medicinteknik. Bolaget är specialiserat inom utveckling av medicintekniska produkter. Produktportföljen är bred och inkluderar plattformar och tjänster inom blodanalyser som används i sjukdomsförebyggande syfte. Utöver huvudverksamheten erbjuds även service och tillhörande kringtjänster. Verksamheten drivs globalt med störst närvaro i Europa.

Analysera bolaget i Börsdata!

All ägardata du vill ha finns i Holdings!

Nightingale Health's disease risk detection becomes available in Latvia through Professor Skride's Heart Clinic

2026-09-29 08:00:00

Nightingale Health Plc | Press Release | September 29, 2026 at 09:00:00 EEST

Nightingale Health and Professor Skride's Heart Clinic, a private cardiology clinic in Riga, have entered into a service agreement to offer the Nightingale Health Check in Latvia. The clinic offers the test under its own brand, the Future Health Test. The test assesses a person's risk of developing five common chronic diseases over the next 10 years from a single blood sample, and bookings are already open.

Under the agreement, Professor Skride's Heart Clinic offers the test to its clients, and Nightingale Health analyses the blood samples. From a single blood sample, the Nightingale Health Check produces a 10-year risk estimate for five chronic diseases: heart attack, ischemic stroke, type 2 diabetes, chronic kidney disease, and fatty liver disease. The report also includes the person's Metabolic Age and Metabolic Resilience Score, and shows their blood values, including cholesterol, triglycerides, and kidney function. The clinic's doctors make all clinical decisions under existing medical guidelines; the test helps them identify earlier who would benefit most from preventive action. The test is recommended to be repeated after 3 to 12 months to follow how a person's risks change.

Professor Skride's Heart Clinic’s mission is to extend the average life expectancy in Latvia by seven healthy years, and prevention is a central part of its work. According to the OECD and European Observatory Country Health Profile 2025 for Latvia, life expectancy in Latvia was 76.7 years in 2024, five years below the EU average. Cardiovascular diseases cause more than half of all deaths in the country. The Future Health Test adds early risk detection to the clinic's preventive services. It shows a person's disease risks before symptoms appear, so that the person and their doctor have time to act. 

"High-quality treatment alone will not give Latvians seven more healthy years; we also need to identify risk in time to act on it. The Future Health Test gives our clients and our doctors a clinically validated picture of their risk of common chronic diseases from a single blood sample. It fits into the preventive services we already offer," says Dins Smits, Co-Founder and Board Member of Professor Skride's Heart Clinic.

"The risk of cardiovascular disease builds up for years before symptoms appear, and a cardiology clinic with prevention at the centre of its mission is the natural place to detect that risk early. With the Future Health Test, people in Latvia can now learn their disease risks from one blood sample while there is still time to act. Latvia is a new market for us, and Professor Skride's Heart Clinic is a strong partner to start with," says Teemu Suna, CEO and Founder of Nightingale Health.

The Future Health Test can be booked at Professor Skride's Heart Clinic in Riga. More information: https://skride.lv/en/service/future-health-test/

About Professor Skride's Heart Clinic
Professor Skride's Heart Clinic (SIA Profesora Skrides Sirds klīnika) is a private cardiology clinic in the centre of Riga, Latvia, opened in May 2024. Founded and led by cardiologist Professor Andris Skride, the clinic brings together specialists from several disciplines, including cardiologists, heart surgeons, endocrinologists, nutritionists, and physiotherapists. It offers specialist consultations, diagnostic examinations, and preventive health packages. The clinic's mission is to extend the average life expectancy in Latvia by seven healthy years. Read more: https://skride.lv/en/

For Professor Skride's Heart Clinic enquiries: info@skride.lv, +371 60007701